Open in PodwiseOpen

Podcast cover

Fierce Life Sciences · Business

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.

Episodes

A closer look at Fierce Biotech's Fierce 15

What 'The Next Berlin Patient' and a PrEP’s 100% efficacy mean for HIV drug development

Fierce 15: Where are they now?

Former FTC director weighs in on Novo's $16.5B deal with Catalent

Find out what to expect from the PDA/FDA Joint Regulatory Conference (Sponsored by Parenteral Drug Association)

A look at Big Pharma’s top-paid CEOs

The best biopharma M&A deals

A closer look at 'friend-shoring' and the drug shortage challenge

Inside this year’s ASCO: Biggest data drops, trends and the best exhibit booth

A look at the top 10 pharma drug ad spenders

A cell therapy reckoning

Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)

[Sponsored] Opportunities & Challenges of Digital Pathology Adoption in CDx Development

[Sponsored] Unlocking health equity: The promise of digital health technologies

Advancements in cell & gene therapy manufacturing (Part II)

Fulfilling the promise of cell & gene therapies through manufacturing (Part I)

A closer look at 2023's top biopharma deals and what lies ahead

A look at pharma revenue rankings

Winning formulas for the best biotech and drug names

[Sponsored] What does the future of specialist distribution look like?

Page 8

Follow this podcast in Podwise

Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.

Open in Podwise